For World Heart Day 2025, observed annually on Sept. 29 to raise public awareness of cardiovascular diseases and their prevention, Healthcare IT News has been tracking new technologies – and new ...

BOSTON--(BUSINESS WIRE)--Elucid has announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its PlaqueIQ™ imaging analysis software to help physicians diagnose ...

Elucid, an AI medical technology company focused on providing physicians with a more precise view of atherosclerosis to drive patient-specific therapeutic decisions, today announced that its Plaque-IQ ...

SAN FRANCISCO, April 15, 2026--(BUSINESS WIRE)--Bunkerhill Health, an agentic AI company building healthcare’s system of action, today announced that the Centers for Medicare and Medicaid Services ...

In the original HOPE trial, a total of 9541 patients aged ≥ 55 years at high risk for cardiovascular events, but who did not have left ventricular dysfunction or heart failure, were randomized in a ...

A pooled analysis of three large trials failed to demonstrate significant reductions in cardiovascular death with finerenone, but significantly lower all-cause mortality, cardiovascular events and ...

WHIPPANY, N.J.--(BUSINESS WIRE)--The study design and baseline characteristics of FINE-HEART, a new prespecified, exploratory pooled analysis of three Phase III trials with finerenone 1, were ...

A great cardiac program can boost patient volume, improve your hospital’s reputation and significantly increase revenue. Here five cardiology program experts — three from the hospitals ranked as ...

In a multicenter, randomized, double-blind, placebo-controlled, noninferiority trial, we enrolled 5246 men 45 to 80 years of age who had preexisting or a high risk of cardiovascular disease and who ...

In a recent study published in the journal Nutrients, researchers performed a meta-analysis to determine the association between fish consumption and cardiovascular disease (CVD) risk. The Importance ...